Sex differences in nevirapine disposition in HIV-infected patients
- 1 November 2003
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (16), 2399-2400
- https://doi.org/10.1097/00002030-200311070-00018
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Pharmacokinetic Variability Caused by Gender: Do Women Have Higher Indinavir Exposure Than Men?JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patientsAIDS, 2001
- Sex Differences in Nevirapine RashClinical Infectious Diseases, 2001
- Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroidsAIDS, 2000
- Differences Between Women and Men in Adverse Events and CD4+ Responses to Nucleoside Analogue Therapy for HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoringAIDS, 1999
- Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1995